Skip to main content
Clinical Trials/NL-OMON31939
NL-OMON31939
Completed
Not Applicable

Proxy measurements in Multiple Sclerosis - Proxy measurements in Multiple Sclerosis

Vrije Universiteit Medisch Centrum0 sites300 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
300
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria patients:
  • 1\. Adult (\>18 years)
  • 2\. Multiple Sclerosis according to McDonald criteria
  • 3\. Signed informed consent;Inclusion criteria proxy respondents:
  • 1\. Adult (\>18 years)
  • 2\. Partner of the patient
  • 3\. Signed informed consent

Exclusion Criteria

  • Exclusion criteria patients:
  • 1\. Severe cognitive impairment which makes it impossible to complete a questionnaire.
  • 2\. When the patient does not have a partner;Exclusion criteria proxy respondents:
  • 1\. When the proxy respondent is not the partner of the patient

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Accurate multiple sclerosis atrophy measurement systemMultiple Sclerosis10012303
NL-OMON51042Vrije Universiteit Medisch Centrum40
Active, not recruiting
Not Applicable
Characterisation of multiple sclerosis pathology by ultra small particles of iron oxide (USPIO)” in comparison with conventional and advanced MRI imaging techniques[Charakterisierung der Multiple Sklerose Pathologie durch ultra small particles of iron oxide (USPIO)” im Vergleich zu konventionellen und fortgeschrittenen MRT Techniken] - MS_USPIO_MPIPPatients with Multiple Sclerosis (MS, N=90) and patients with a clinically isolated syndrome (ref. to as CIS in literature, i. e. not a clinically definite MS but a syndrome that may occur as first sign of MS early in the course, N=15) are planned to be investigated in the proposed clinical trial.MedDRA version: 8.1Level: LLTClassification code 10028245Term: Multiple sclerosis
EUCTR2006-001337-17-DEMax-Planck-Institute of Psychiatry
Completed
Not Applicable
Diagnostic criteria for Multiple Sclerosis: Impact of high field Magnetic Resonance ImagingMSmultiple sclerosis1000381610012303
NL-OMON40083Vrije Universiteit Medisch Centrum30
Completed
Not Applicable
Multiple sclerosis lesion characterization on ultra-high-field MRI: Comparative pilot study of 9.4 vs 7 vs 3 teslaMSmultiple sclerosis10012303
NL-OMON52035Zuyderland Medisch Centrum10
Completed
Not Applicable
3 Meter Backwards Walk Test and Multiple SclerosisMultiple SclerosisWalking, DifficultyBalance; Distorted
NCT04004026Sanko University40